請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56768
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李明學(Ming-Shyue Lee) | |
dc.contributor.author | Han-Yun Hsieh | en |
dc.contributor.author | 謝函芸 | zh_TW |
dc.date.accessioned | 2021-06-16T05:47:15Z | - |
dc.date.available | 2017-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-11 | |
dc.identifier.citation | 1.Zhe Lu, L.D., Qun Lu and Yan-Hua Chen, Claudins in intestines- Distribution and functional significance in health and diseases. Tissue Barriers, 2013. 1(3): p. 24978-1~24978-14.
2.Jun Miyoshia, Y.T., Molecular perspective on tight-junctionassembly and epithelial polarity. Advanced Drug Delivery Review, 2005. 57: p. 815-855. 3.Shoichiro Tsukita, M.F.M.I., Multifunctional strands in tight junctions. Nature Reviews Molecular Cell Biology 2001. 2: p. 285-293. 4.J. P. Chalcroft, a.S.B., An interpertation of liver cell membrane and junction structure base on observation of freeze-fracture replicas of both sides of fracture. The journal of cell biology, 1970. 47: p. 49-60. 5.Findley, M.K. and M. Koval, Regulation and roles for claudin-family tight junction proteins. IUBMB Life, 2009. 61(4): p. 431-7. 6.Singh, A.B., A. Sharma, and P. Dhawan, Claudin family of proteins and cancer: an overview. J Oncol, 2010. 2010: p. 541957. 7.Matter, M.S.B.a.K., Tight junctions at aglance. Journal of Cell Science, 2008. 121: p. 3677-3682. 8.Shen, L., Tight junctions on the move: molecular mechanisms forepithelial barrier regulation. Ann N Y Acad Sci. , 2012. 1258: p. 9-18. 9.Matthijs R. H. Kooistra, N.D.a.J.L.B., Rap1: a key regulator in cell-cell junction formation. Journal of Cell Science, 2007. 120: p. 17-22. 10.Mathis, C.B.a.D., Mast cells in autoimmune disease. Nature 2002. 420: p. 19-26. 11.Anthony J. Viera, S.H., and Joseph Shaughnessy, Management of Irritable Bowel Syndrome. American Family Physician, 2002. 6(10): p. 1867-1874. 12.Buzza, M.S., et al., Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway. J Biol Chem, 2013. 288(15): p. 10328-37. 13.Buzza, M.S., et al., Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci U S A, 2010. 107(9): p. 4200-5. 14.Ariane Paoloni-Giacobino, H.C., Manuel C. Peitsch, Colette Rossier, and Stylianos E. Antonarakis, Cloning of the TMPRSS2 Gene, Which Encodes a Novel Serine Protease with Transmembrane, LDLRA, and SRCR Domains and Maps to 21q22.3. GENOMICS, 1997. 44: p. 309-320. 15.Biaoyang Lin, C.F., James T. White, Shunyou Wang, Robert Vessella, Lawrence D. True, Leroy Hood, and Peter S. Nelson, Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2. Cancer Research, 1999. 59: p. 4180-4184. 16.Susan Wilson, B.g., John Hooper, Andries Zijlstra, Brian Walker, James Quigley and Susan Hawthorne, The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem. J, 2005. 388: p. 967-972. 17.Chen, Y.W., et al., TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol, 2010. 176(6): p. 2986-96. 18.Tom S. Kim, C.H., Robert C. Hackman, and Peter S. Nelson, Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease. Molecular and Cellular biology, 2006. 26(3): p. 965-975. 19.Francesca Demichelis, M.A.R., TMPRSS2-ETS fusion prostate cancer: biological and clinical implications. J Clin Pathol, 2007. 60: p. 1185-1186. 20.Salagierski, M. and J.A. Schalken, Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion. J Urol, 2012. 187(3): p. 795-801. 21.Yuenian E. Shi, J.T., Lynn Yieh, Anton Wellstein, Marc E. Lippman, and Robert B.Dickson, Identification and Characterization of a Novel Matrix-degrading Protease from Hormone-dependent Human Breast Cancer Cells. Cancer Research, 1993. 53(6): p. 1049-15. 22.Toshihiko Takeuchi, M.A.S., and Charles S. Craik, Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA, 1999. 96(20): p. 11054-61. 23.Cao J, C.X., Zheng L, Geng L, Shi Z, Pao CC, Zheng S, Characterization of colorectal-cancer-related cDNA clones obtained by subtractive hybridization screening. J Cancer Res Clin Oncol, 1997. 123(8): p. 447-51. 24.Santin AD, C.S., Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T, Pecorelli S, The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma. Cancer, 2003. 98(9): p. 1898-904. 25.Lee, M.-S., Matrix-Degrading Type II Transmembrane Serine Protease Matriptase: Its Role in Cancer Development and Malignancy. J. Cancer Mol, 2006. 2(5): p. 183-190. 26.Chungho Kim, Y.C., Chan-Hee Kang, MoonGyoKim, HyoSeonLee, Eun-Gyung Cho and DongeunPark, Filamin is essential for shedding of the transmembraneserine protease, epithin. EMBO report, 2005. 293(1): p. 1045-1051. 27.Oberst MD, W.C., Dickson RB, Johnson MD, Lin CY, The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem, 2003. 278(29): p. 26733-9. 28.Michael D. Oberst, L.-Y.L.C., Ken-Ichi Kiyomiya, Cicely A. Williams, Ming-Shyue Lee, Michael D. Johnson, Robert B. Dickson, and Chen-Yong Lin, HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol, 2005. 289: p. 462-470. 29.Ken-ichi Kiyomiya, M.-S.L., I-Chu Tseng, Hong Zuo, Robert J. Barndt, Michael D. Johnson, Robert B. Dickson and Chen-Yong Lin, Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. Am J Physiol Cell Physiol, 2006. 291: p. 40-49. 30.Jehng-Kang Wang, M.-S.L., I-Chu Tseng, Feng-Pai Chou, Ya-Wen Chen, Amy Fulton, Herng-Sheng Lee, Cheng-Jueng Chen, Michael D. Johnson and Chen-Yong Lin, Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am J Physiol Cell Physiol. 2009. 297: p. 459-470. 31.Szabo, R., Uzzun Sales, K. Kosa, P. Shylo, N. A. Godiksen, S. Hansen, K. K. Friis, S. Gutkind, J. S. Vogel, L. K. Hummler, E. Camerer, E. Bugge, T. H., Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet, 2012. 8(8): p. e1002937. 32.Yu JX, C.L., Chao J. P, Postasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J Biol Chem. , 1994. 269(29): p. 18843-18848. 33.Chen, L.M., et al., Prostasin is a glycosylphosphatidylinositol-anchored active serine protease. J Biol Chem, 2001. 276(24): p. 21434-42. 34.Chen, L.M., X. Zhang, and K.X. Chai, Regulation of prostasin expression and function in the prostate. Prostate, 2004. 59(1): p. 1-12. 35.Miller, G.S. and K. List, The matriptase-prostasin proteolytic cascade in epithelial development and pathology. Cell Tissue Res, 2013. 351(2): p. 245-53. 36.Netzel-Arnett, S., et al., Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem, 2006. 281(44): p. 32941-5. 37.Friis, S., et al., Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase. J Biol Chem, 2011. 286(7): p. 5793-802. 38.Selzer-Plon, J., et al., Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer, 2009. 9: p. 201. 39.L.M. Chen, X.Z., K.X. Chai, Regulation of prostasin expression and function in the prostate. Prostate, 2004. 59: p. 1-12. 40.Fogh J, F.J., T.Orfeo One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977. 59(1): p. 221-6. 41.Hidalgo IJ, R.T., Borchardt RT, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 1989. 96(3): p. 736-49. 42.Gaush CR, H.W., Smith TF, Characterization of an Established Line of Canine Kidney Cells (MDCK). Exp Biol Med (Maywood) 1966. 122(3): p. 931-5. 43.Alvarez-Hernandez X, N.G., Glass J., Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers. Biochim Biophys Acta., 1991 1070(1): p. 205-8. 44.Claudia Istrate, M.H., Elena Vikstrom, Karl-Eric Magnusson and Lennart Svenssonb, Rotavirus Infection Increases Intestinal Motility but Not Permeability at the Onset of Diarrhea. J. Virol., 2014. 88(6): p. 3161-3169. 45.Juan, C.-P., Role of TMPRSS2 in tight junction formation of Caco-2 cells. Master thesis of National Taiwan University, 2013. 46.Ya-Wen Chen, J.-K.W., Feng-Pai Chou, Chiu-Yuan Chen, Ellen A. Rorke, Li-Mei Chen, Karl X. Chai, Richard L. Eckert, Michael D. Johnson and Chen-Yong Lin, Regulation of the Matriptase-Prostasin Cell SurfaceProteolytic Cascade by Hepatocyte Growth Factor ActivatorInhibitor-1 during Epidermal Differentiation. The journal of biological chemistry, 2010. 285: p. 31755-31762. 47.Shilpa Nimishakavi, M.B., Wilfred W. Raymond, Charles S. Craik, Dieter C. Gruenert, and George H. Caughey, Activity and inhibition of prostasin and matriptase on apical and basolateral surfaces of human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2012. 303: p. 97-106. 48.Szabo, R. and T.H. Bugge, Membrane-anchored serine proteases in vertebrate cell and developmental biology. Annu Rev Cell Dev Biol, 2011. 27: p. 213-35. 49.Friis, S., et al., A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation. J Biol Chem, 2013. 288(26): p. 19028-39. 50.Diane E. Peters, R.S., Stine Friis, Natalia A. Shylo, Katiuchia Uzzun Sales, Kenn Holmbeck, and Thomas H. Bugge, The Membrane-Anchored Serine Protease Prostasin (CAP1/PRSS8) Supports Epidermal Development and Postnatal Homeostasis Independent of its Enzymatic Activity. The journal of Biological Chemistry, 2014. 289(21): p. 14740-14749. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56768 | - |
dc.description.abstract | 細胞連接在維持體內組織的滲透壓平衡中扮演著重要的角色。在近期研究中發現,第二型嵌膜絲胺酸蛋白酶 (TTSP)中的成員,間質蛋白酶 (matriptase) 與攝護腺蛋白酶(prostasin)在大腸腺癌上皮細胞 (Caco-2)的緊密連接的形成過程中扮演正向調控的角色。由先前本實驗的研究結果顯示,另一個TTSP的成員,第二型嵌膜蛋白酶 (TMPRSS2)會活化matriptase, 並參與細胞緊密連接的形成。 然而,TMPRSS2, matriptase及prostasin三者在腸道上皮細胞緊密連接形成過程中,所扮演的角色,仍有許多未知。在本研究中,我們假設TMPRSS2, matriptase及prostasin會形成一個嵌膜蛋白酶疊層,進而影響腸道上皮細胞的細胞緊密連接的形成及通透性。結果顯示TMPRSS2是一個位於matriptase及prostasin上游的調控者。利用TEER測量Caco-2及MDCK細胞的離子通透性可發現,過量表達的TMPRSS2及prostasin都會增加細胞間緊密連接的形成並使離子通透性降低。抑制prostasin的表現量則會降低緊密連接形成以及增加細胞通透性。當在過量表達TMPRSS2的Caco-2細胞中降低matriptase的表現量,將會降低由TMPRSS2所促進的細胞緊密連接並增高其通透性。第一型肝細胞生長因子活化抑制蛋白 (HAI-1)被報導為可抑制matriptase 和prostasin的活性。因此,想進一步探討是否HAI-1的表達藉由抑制matriptase 和prostasin,進而壓抑由TMPRSS2所促進的細胞緊密連接。由細胞離子通透性實驗發現,過量表達的HAI-1,明顯地將TMPRSS2促進細胞提早分化的情形壓抑下來。綜合以上結果,TMPRSS2與prostasin及matriptase在細胞緊密連接過程中均扮演角色,且TMPRSS2是matriptase及prostasin上游的調節蛋白酶,調控細胞緊密連接的形成及通透性。 | zh_TW |
dc.description.abstract | Junction barriers play a protective role in the tissue homeostasis. Recent studies have shown that type II transmembrane serine proteases (TTSP) matriptase and prostasin have a positive role in tight junction formation. Our preliminary data further showed that another TTSP TMPRSS2 could induce matriptase activation and be involved in junction barrier formation. How the pericellular proteolysis among TMPRSS2, matriptase and prostasin plays a role in junction barrier formation and permeability remain largely unknown. In this study, we hypothesized that a pericellular proteolytic cascade among TMPRSS2, matriptase and prostasin exists and can affect the tight junction formation and permeability of colorectal epithelial cells. The results showed that TMPRSS2 acted as an upstream regulator for matriptase and prostasin in human epithelial cells. Moreover, the results from the TransEpithelial Electric Resistance (TEER) analysis showed that TMPRSS2 and prostasin overexpression increased the formation of tight junction in colorectal cancer Caco-2 cells and MDCK cells. Prostasin knockdown in Caco-2 cells reduced the tight junction formation and increased the permeability of the polarized cells. Furthermore, matriptase knockdown in TMPRSS2-overexpressing Caco-2 cells inhibited TMPRSS2 function on the barrier formation and increase the ionic paracellular permeability. Overexpression of hepatocyte growth factor activator inhibitor (HAI-1) could decrease the barrier formation induced by TMPRSS2. The results together indicate that TMPRSS2 is an upstream regulator of matriptase and prostasin to affect the barrier formation and permeability in epithelial cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T05:47:15Z (GMT). No. of bitstreams: 1 ntu-103-R01442007-1.pdf: 6343245 bytes, checksum: 5442cd99616604d4379fb1fc22760750 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 摘要.....................................................1
Abstract................................................3 Chapter 1. Introduction.................................1 1.1 Tight junction and serine protease..................2 1.2 TMPRSS2 (Type II transmembrane protease serine 2)...4 1.3 Matriptase..........................................6 1.4 Prostasin...........................................8 1.5 Research motivation................................10 Chapter 2. Materials and Methods.......................11 2.1 Materials..........................................12 2.2 Methods............................................16 Chapter 3. Results.....................................24 3.1 Transcient transfection of TMPRSS2, matriptase and prostasin in HEK293T cells.............................25 3.2 Prostasin played a role in regulating the junction formation and macromolecule permeability of Caco-2 cells and matriptase.........................................26 3.3 Prostasin overexpression enhanced the barrier formation during the cell differentiation and serine protease matriptase activation.........................27 3.4 Analysis of TEER values and tight junction protein expression on prostasin-overexpressing MDCK cells......29 3.5 Role of matriptase in the TMPRSS2-overexpressing Caco-2 cells...........................................30 3.6 Role of HAI-1 in the TMPRSS2-overexpressing Caco-2 cells..................................................31 3.7 Effect of protein expression levels of matriptase, prostasin, adherenes and tight junction proteins in prostasin-knockdown or -overexpressing Caco-2 cells....32 Chapter 4. Discussion..................................34 Chapter 5. Figures.....................................39 Chapter 6. References..................................70 | |
dc.language.iso | en | |
dc.title | 探討嵌膜蛋白酶在人類大腸上皮細胞間緊密連接形成過程中扮演的角色 | zh_TW |
dc.title | Delineation of membrane-anchored serine proteases in tight junction formation of colorectal epithelial cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 余佳慧(Linda Chia-Hui Yu),王正康(Jehng-Kang, Wang),余明俊(Ming-Jiun Yu) | |
dc.subject.keyword | 細胞緊密連接,第二型嵌膜蛋白?,間質蛋白?,攝護腺蛋白?, | zh_TW |
dc.subject.keyword | TMPRSS2,prostasin,matriptase,tight junction, | en |
dc.relation.page | 73 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-08-11 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 6.19 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。